239 related articles for article (PubMed ID: 21529781)
1. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders.
Carter CS; Barch DM; Bullmore E; Breiling J; Buchanan RW; Butler P; Cohen JD; Geyer M; Gollub R; Green MF; Jaeger J; Krystal JH; Moore H; Nuechterlein K; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T
Biol Psychiatry; 2011 Jul; 70(1):7-12. PubMed ID: 21529781
[TBL] [Abstract][Full Text] [Related]
2. Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development.
Carter CS; Barch DM;
Schizophr Bull; 2012 Jan; 38(1):26-33. PubMed ID: 21914642
[TBL] [Abstract][Full Text] [Related]
3. Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations.
Barch DM; Mathalon DH
Biol Psychiatry; 2011 Jul; 70(1):13-8. PubMed ID: 21334602
[TBL] [Abstract][Full Text] [Related]
4. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative.
Carter CS; Barch DM; Buchanan RW; Bullmore E; Krystal JH; Cohen J; Geyer M; Green M; Nuechterlein KH; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T; Heinssen R
Biol Psychiatry; 2008 Jul; 64(1):4-10. PubMed ID: 18466880
[TBL] [Abstract][Full Text] [Related]
5. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.
Barch DM; Carter CS;
Schizophr Bull; 2008 Jul; 34(4):613-8. PubMed ID: 18499705
[TBL] [Abstract][Full Text] [Related]
6. Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.
Moore H; Geyer MA; Carter CS; Barch DM
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2087-91. PubMed ID: 24090823
[TBL] [Abstract][Full Text] [Related]
7. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
Carter CS; Barch DM
Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
[TBL] [Abstract][Full Text] [Related]
8. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia.
Barch DM; Smith E
Biol Psychiatry; 2008 Jul; 64(1):11-7. PubMed ID: 18400207
[TBL] [Abstract][Full Text] [Related]
9. CNTRICS imaging biomarker selections: Executive control paradigms.
Carter CS; Minzenberg M; West R; Macdonald A
Schizophr Bull; 2012 Jan; 38(1):34-42. PubMed ID: 22114099
[TBL] [Abstract][Full Text] [Related]
10. Brain mapping biomarkers of socio-emotional processing in schizophrenia.
Taylor SF; MacDonald AW;
Schizophr Bull; 2012 Jan; 38(1):73-80. PubMed ID: 21965468
[TBL] [Abstract][Full Text] [Related]
11. Cognitive [Computational] Neuroscience Test Reliability and Clinical Applications for Serious Mental Illness (CNTRaCS) Consortium: Progress and Future Directions.
Barch DM; Boudewyn MA; Carter CC; Erickson M; Frank MJ; Gold JM; Luck SJ; MacDonald AW; Ragland JD; Ranganath C; Silverstein SM; Yonelinas A
Curr Top Behav Neurosci; 2023; 63():19-60. PubMed ID: 36173600
[TBL] [Abstract][Full Text] [Related]
12. Standardization, integration, and sharing-leveraging research investments.
Insel TR; Morris SE; Heinssen RK
Biol Psychiatry; 2011 Jul; 70(1):5-6. PubMed ID: 21672648
[No Abstract] [Full Text] [Related]
13. CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning.
Ragland JD; Cohen NJ; Cools R; Frank MJ; Hannula DE; Ranganath C
Schizophr Bull; 2012 Jan; 38(1):62-72. PubMed ID: 22102094
[TBL] [Abstract][Full Text] [Related]
14. Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia.
Carter CS
Schizophr Bull; 2005 Oct; 31(4):810-5. PubMed ID: 16107584
[TBL] [Abstract][Full Text] [Related]
15. The cognitive neuroscience of memory function and dysfunction in schizophrenia.
Ranganath C; Minzenberg MJ; Ragland JD
Biol Psychiatry; 2008 Jul; 64(1):18-25. PubMed ID: 18495087
[TBL] [Abstract][Full Text] [Related]
16. Executive functioning component mechanisms and schizophrenia.
Kerns JG; Nuechterlein KH; Braver TS; Barch DM
Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
[TBL] [Abstract][Full Text] [Related]
17. CNTRICS final biomarker selection: Control of attention.
Luck SJ; Ford JM; Sarter M; Lustig C
Schizophr Bull; 2012 Jan; 38(1):53-61. PubMed ID: 21765166
[TBL] [Abstract][Full Text] [Related]
18. Visual perception and its impairment in schizophrenia.
Butler PD; Silverstein SM; Dakin SC
Biol Psychiatry; 2008 Jul; 64(1):40-7. PubMed ID: 18549875
[TBL] [Abstract][Full Text] [Related]
19. CNTRICS imaging biomarkers selection: Working memory.
Barch DM; Moore H; Nee DE; Manoach DS; Luck SJ
Schizophr Bull; 2012 Jan; 38(1):43-52. PubMed ID: 22080498
[TBL] [Abstract][Full Text] [Related]
20. Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia.
Cho RY; Ford JM; Krystal JH; Laruelle M; Cuthbert B; Carter CS
Schizophr Bull; 2005 Oct; 31(4):865-9. PubMed ID: 16166611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
